Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sight Sciences (SGHT) Change in Accured Expenses (2020 - 2025)

Historic Change in Accured Expenses for Sight Sciences (SGHT) over the last 6 years, with Q3 2025 value amounting to $965000.0.

  • Sight Sciences' Change in Accured Expenses fell 3349.41% to $965000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$1.7 million, marking a year-over-year decrease of 19202.82%. This contributed to the annual value of $5.2 million for FY2024, which is 21185.67% up from last year.
  • Per Sight Sciences' latest filing, its Change in Accured Expenses stood at $965000.0 for Q3 2025, which was down 3349.41% from $101000.0 recorded in Q2 2025.
  • Over the past 5 years, Sight Sciences' Change in Accured Expenses peaked at $3.4 million during Q2 2021, and registered a low of -$4.6 million during Q1 2025.
  • In the last 5 years, Sight Sciences' Change in Accured Expenses had a median value of $101000.0 in 2025 and averaged $84736.8.
  • Its Change in Accured Expenses has fluctuated over the past 5 years, first crashed by 138125.0% in 2021, then surged by 84410.26% in 2024.
  • Over the past 5 years, Sight Sciences' Change in Accured Expenses (Quarter) stood at $1.3 million in 2021, then tumbled by 53.45% to $628000.0 in 2022, then tumbled by 341.4% to -$1.5 million in 2023, then skyrocketed by 218.14% to $1.8 million in 2024, then crashed by 46.12% to $965000.0 in 2025.
  • Its Change in Accured Expenses was $965000.0 in Q3 2025, compared to $101000.0 in Q2 2025 and -$4.6 million in Q1 2025.